Novartis

Find Novartis ads at NewsNow Classifieds/Jobs

Novartis receives European and UK licence for Kesimpta®▼(ofatumumab), the first… Pharmaceutical Field15:03
Novartis (NVS) teams up with Artios for Radioligand Therapies Nasdaq20:39
Artios, Novartis form cancer therapies collaboration PharmaTimes09:05
Novartis taps DNA damage specialist Artios in $1.3B discovery deal to complement growing radioligand portfolio ENDPOINTS07:01
Novartis taps Artios for targets to enhance radioligand drugs FierceBiotech07:07
Artios Pharma announces collaboration with Novartis to create next generation DDR cancer therapies GlobeNewswire (Press Release)07:06

Latest News

In the last 7 days
Deal Watch: Artios Links Up With Novartis On DNA Damage Response Modifiers Scrip Pharma Intelligence21:30 9-Apr-21
Insights on the Myasthenia Gravis Drugs Global Market to 2027 - Featuring Novartis… PR Newswire (Press Release)20:21 9-Apr-21
Novartis receives European and UK licence for Kesimpta®▼(ofatumumab), the first… Pharmaceutical Field15:03 9-Apr-21
Novartis (NVS) Teams Up With Artios for Radioligand Therapies Nasdaq20:39 8-Apr-21
Teva Aims To Revoke Rival's Blood Transfusion Drug Patent Law36015:27 8-Apr-21
Artios Pharma to collaborate with Novartis on DDR cancer therapies European Pharmaceutical Manufacturer12:23 8-Apr-21
Novartis MS therapy gains MHRA and EC approval Pharmafile11:18 8-Apr-21
Worldwide Neuroendocrine Tumor Treatment Industry to 2029 - Players Include Advanced… Business Wire (Press Release)10:57 8-Apr-21
Novartis bags EU, UK licences for MS therapy Kesimpta PharmaTimes09:20 8-Apr-21
Novartis expands in radio-oncology again with $1.3bn Artios alliance pharmaphorum09:03 8-Apr-21
Artios, Novartis combining DDR approach with radioligands in three-year, $1.3B deal BioWorld22:53 7-Apr-21
In brief: Arix Bioscience investee Artios collaborates with Novartis London South East20:05 7-Apr-21
Novartis, Artios Pharma Target Cancer in Up-to-$1.3B DDR Collaboration Genetic Engineering and Biotechnology News19:52 7-Apr-21
Artios, Novartis Aim to Develop and Discover DDR Targets for Cancer in New Pa... BioSpace15:43 7-Apr-21
Novartis and Artios Pharma to collaborate on DDR cancer therapies Pharmafile11:11 7-Apr-21
Novartis UK announces further HRT patch stock issues PharmaTimes09:56 7-Apr-21
Artios clinches minimum $1.5bn from Novartis for cancer assault Business Weekly09:48 7-Apr-21
Artios, Novartis form cancer therapies collaboration PharmaTimes09:05 7-Apr-21
Arix portfolio firm Artios Pharma to collaborate with Novartis on cancer therapy development Proactive Investors (UK)08:05 7-Apr-21
Novartis taps Artios for targets to enhance radioligand drugs FierceBiotech07:07 7-Apr-21
Artios Pharma Announces Collaboration with Novartis to Create Next Generation DDR Cancer Therapies GlobeNewswire (Press Release)07:06 7-Apr-21
Novartis taps DNA damage specialist Artios in $1.3B discovery deal to complement growing radioligand portfolio ENDPOINTS07:01 7-Apr-21
Esya Labs Provides Novel Research Assays to Accelerate Drug Discovery Efforts Business Wire (Press Release)15:54 6-Apr-21
Amphista Therapeutics raises $53M in oversubscribed Series B round to advance next generation targeted protein… UK BioIndustry Association11:32 6-Apr-21
Worldwide Vascular Endothelial Growth Factor Inhibitor Industry to 2030 - Players Include… Business Wire (Press Release)10:31 6-Apr-21
Human Vaccines Market Swot Analysis by key players Novartis AG, CSL, Mymetics Industry Today13:33 5-Apr-21
Ex-minister of justice to testify in Novartis case ekathimerini.com06:13 5-Apr-21
In the last month
Global Nasopharyngeal Cancer Clinical Trials Review, H2 2020 Report Featuring Sanofi, E. Merck, … Business Wire (Press Release)15:08 2-Apr-21
Novartis AG – Consensus Indicates Potential 22.4% Upside DirectorsTalk Interviews13:04 2-Apr-21
Are Ultra-High Drug Prices Sustainable? Nasdaq14:22 1-Apr-21
Cutting loose from Merck, Mike Nally is 'running toward a great opportunity'; Novartis partnership in hand, BeiGene… ENDPOINTS14:17 1-Apr-21
Novartis builds radio-oncology pipeline with iTheranostics deal pharmaphorum14:12 1-Apr-21
Immunotherapy Drugs Industry Assessment 2021 Featuring Comprehensive Profiles of Amgen, Bayer,… Business Wire (Press Release)09:58 1-Apr-21
Italy's top court sends Roche-Novartis revocation request to ECJ Thomson Reuters - Practical Law09:13 1-Apr-21
EU approval of Novartis’ Kesimpta offers treatment that can be self-administered, but Roche’s… Pharmaceutical Technology15:58 31-Mar-21
Although Novartis’ Kesimpta can be self-administered, it will not be market leader currently, says GlobalData GlobalData15:21 31-Mar-21
EC approves Novartis’s Kesimpta for relapsing multiple sclerosis Pharmaceutical Technology14:06 31-Mar-21
Bristol Myers Squibb's Zeposia and Biogen's Vumerity Place Competitive Pressure on Established… PR Newswire (Press Release)13:09 31-Mar-21
Novartis bolsters radioligand therapy pipeline with new licence agreement PMLiVE13:00 31-Mar-21
EU approval for Novartis’ treatment of relapsing forms of MS Pharmaceutical Field10:32 31-Mar-21
Hospital Pharmaceuticals Market to Set New Growth Story | Pfizer, Johnson and Johnson,… Industry Today09:35 31-Mar-21
Peptone announces a collaboration with NVIDIA and Verne Glob… Total Telecom17:35 30-Mar-21
Novartis goes nuclear, again Evaluate Group15:58 30-Mar-21
Novartis bolsters radioligand stable with iTheranostics deal FierceBiotech15:48 30-Mar-21
Worldwide Antibiotics Industry to 2026 - Featuring Pfizer, Bayer and Novartis Among Others PR Newswire (Press Release)15:08 30-Mar-21
Novartis dives even deeper into radioligands, notching licensing deal with iTheranostics for multiple compounds ENDPOINTS13:53 30-Mar-21
Worldwide Dermatology Drugs Industry to 2030 - Featuring Allergan, Galderma and Novartis Among… Business Wire (Press Release)13:07 30-Mar-21
Novartis gains EU approval for relapsing MS drug Kesimpta PMLiVE12:34 30-Mar-21
SOFIE affiliate, iTheranostics, executes agreement for its promising library of Fibroblast… PR Newswire (Press Release)12:07 30-Mar-21
Novartis expands targeted radioligand therapy pipeline Biopharma Reporter11:01 30-Mar-21
Roche, Novartis approvals in Europe signal more head-to-head competition Reuters07:50 30-Mar-21
Novartis says Kesimpta gets EU approval in multiple sclerosis Reuters07:00 30-Mar-21
Novartis receives EU approval for Kesimpta® (ofatumumab), the first and only self-administered, targeted B-cell therapy … Novartis (Press Release)06:58 30-Mar-21
Genmab Announces European Marketing Authorization for Kesimpta® (ofatumumab) in Relapsing Multiple Sclerosis GlobeNewswire (Press Release)06:27 30-Mar-21
Novartis expands targeted radioligand therapy pipeline with in-license for compounds targeting Fibroblast Activation… GlobeNewswire (Press Release)06:17 30-Mar-21
Novartis and Genentech push for clarity from FDA on how disease progression models can be used for regulatory decisions ENDPOINTS20:51 29-Mar-21
Valeo Pharma shares get a boost as it unveils deal with Novartis on two Health Canada approved… Proactive Investors (USA & Canada)19:30 29-Mar-21
Valeo Pharma Inc. Enters into an Agreement for Enerzair & Breezhaler and Atectura Breezhaler in Canada BioSpace19:24 29-Mar-21
Global Chronic Myeloid Leukemia (CML) Treatment Market to 2029 - Featuring Novartis,… Business Wire (Press Release)14:18 29-Mar-21
Novartis UK and NHS spin-out Cievert announce digital innovation partnership MobiHealthNews13:19 29-Mar-21
Global Eye Allergy Therapeutics Market Trajectory & Analytics Report 2021 Featuring Akorn,… Business Wire (Press Release)11:56 29-Mar-21
Global Spinal Muscular Atrophy Disease Insights and Market Forecasts 2020-2026 Featuring Chugai … Business Wire (Press Release)11:15 29-Mar-21
Worldwide Insights on the Neurofibromatosis Type - 2 Industry to 2030 - Featuring AstraZeneca,… Business Wire (Press Release)11:15 29-Mar-21
Novartis UK signs digital partnership with Cievert for chronic disease management PharmaTimes09:48 29-Mar-21
Novartis closes U.S. gene therapy site as Zolgensma sales fell from Q3 to Q4 Reuters07:01 27-Mar-21
Novartis Says Chair Contradicted Admissions In FCA Deal Law36000:22 27-Mar-21
BioNTech nabs EU approval for Novartis plant tapped in COVID-19 vaccine production push FiercePharma16:08 26-Mar-21
Pfizer's Ibrance, under threat from Novartis and Lilly, leans on real-world data in breast… FiercePharma15:58 26-Mar-21
Novartis Closes Colorado Gene Manufacturing Site 14 Months After Acquisition BioSpace14:50 26-Mar-21
Novartis pushes back on chairman's 'inaccurate and inconsistent' comments undermining bribery settlement ENDPOINTS13:54 26-Mar-21
Novartis Reports Positive Data from Phase 3 VISION Trial of Targeted Radioligand Therapy in Patients with Advanced… Trial Site News22:05 25-Mar-21
Novartis walks away from 3rd Zolgensma plant just a year after leasing it as it pivots resources to next-gen pipeline ENDPOINTS17:14 25-Mar-21
Novartis Picks New Chief Legal Officer Focused on Diversity Law.com Corporate Counsel16:52 25-Mar-21
Novartis sets the record straight on chairman's $678M kickback settlement comments FiercePharma16:04 25-Mar-21
Global DTP Vaccines Market Report 2020-2030 Featuring Merck & Co, Sanofi, GSK, Lanzhou… PR Newswire (Press Release)15:52 25-Mar-21
Novartis is shutting down Colorado plant, laying off 400 employees after overestimating gene… FiercePharma14:53 25-Mar-21
HHS inspector general signs off on Novartis paying for pricey Kymriah ENDPOINTS14:10 25-Mar-21
LOU-064: An Agammaglobulinaemia Tyrosine Kinase Inhibitors Being Developed by Novartis for… Business Wire (Press Release)10:41 25-Mar-21
Novartis closing Longmont drug facility in July, to lay off 400 Boulder Daily Camera, Colorado17:28 24-Mar-21
Novartis corrects chairman's comments about kickbacks case Reuters15:24 24-Mar-21
Novartis (NVS) Posts Positive Data From Prostate Cancer Study Nasdaq14:13 24-Mar-21
#FierceMadness pharma ad contest narrows: Pfizer, Bayer, Novartis, ViiV and Biohaven among the… FiercePharma12:25 24-Mar-21
Novartis’ radioligand therapy meets phase 3 prostate cancer trial target pharmaphorum11:02 24-Mar-21
Positive Phase III study results for prostate cancer patients from Novartis Pharmaceutical Field10:38 24-Mar-21
‘Novartis' CAR-T therapy Kymriah shows both possibilities, challenges’ Korea Biomedical Review03:22 24-Mar-21
Longmont-made gene therapy significantly extends infant patient survival rate, new data says Boulder Daily Camera, Colorado23:54 23-Mar-21
Novartis statement on comment in Swiss media Novartis (Press Release)19:06 23-Mar-21
Novartis's Targeted Radioligand Improves OS And PFS In Prostate Cancer Scrip Pharma Intelligence17:47 23-Mar-21
Novartis says radioligand therapy improves prostate cancer survival Reuters17:19 23-Mar-21
Novartis’s nuclear vision starts to take shape Evaluate Group16:18 23-Mar-21
Swiss drugmaker Novartis names Karen Hale as new legal chief after GC departs for Moderna The Global Legal Post15:03 23-Mar-21
Novartis' Radioligand Therapy Lives Up to Hype in Phase III Prostate Cancer Trial BioSpace13:39 23-Mar-21
Novartis’ $2B cancer drug spurs ‘groundbreaking’ PhIII data for prostate cancer ENDPOINTS13:18 23-Mar-21
Positive late-stage results for Novartis’ radioligand therapy in advanced prostate cancer PMLiVE12:36 23-Mar-21
Novartis' radioligand hits goal in phase 3 prostate cancer trial FierceBiotech11:59 23-Mar-21
Novartis prostate cancer treatment sees positive Phase III results Pharmafile10:25 23-Mar-21
Human Prion Disease Diagnostics Market, Booming Trends by 2031 | PrioSense Ltd, Bio-Rad… Industry Today09:36 23-Mar-21
Novartis radioligand therapy improves prostate cancer survival Reuters06:35 23-Mar-21
Novartis announces positive result of phase III study with radioligand therapy 177Lu-PSMA-617 in patients with advanced … GlobeNewswire (Press Release)06:16 23-Mar-21
High Court Won't Hear Generic MS Drug Patent Challenge Law36021:28 22-Mar-21
Novartis Names Longtime AbbVie Atty As CLO Law36018:35 22-Mar-21
Novartis poaches AbbVie veteran to be new chief legal officer after losing its own to Moderna FiercePharma16:19 22-Mar-21
Highlights from the Co-Creating Impact Summit 2020 Novartis (Press Release)13:15 22-Mar-21
Novartis Hits Pharma Rival for New Chief Legal Officer Law.com International13:09 22-Mar-21
Novartis joins pharma-wide effort to meet global demand for COVID-19 vaccines Novartis (Press Release)13:05 22-Mar-21
Bayer, Roche, Novo Nordisk, J&J, Novartis and Gilead among the Sweet 16 advancing in… FiercePharma11:53 22-Mar-21
Novartis inaugurates innovative watershed project in India to increase water availability Novartis (Press Release)07:19 22-Mar-21
Regulator to maintain permit for Kymriah without confirmatory trial Korea Biomedical Review06:48 22-Mar-21
Novartis appoints Karen Hale as Chief Legal Officer Novartis (Press Release)06:28 22-Mar-21
Incyte, Novartis aim to make Jakafi available in severe COVID-19 after narrow trial miss FiercePharma15:43 19-Mar-21
J&J nabs FDA nod for Ponvory, joining Novartis, Bristol Myers in crowded MS market FiercePharma14:22 19-Mar-21
Women’s Health Market to See Revolutionary Growth | Lupin Pharmaceuticals, Pfizer, Novartis AG Industry Today10:19 19-Mar-21
Novartis AG – Consensus Indicates Potential 21.7% Upside DirectorsTalk Interviews04:51 19-Mar-21
Inside Novartis' months-long efforts to scale their rivals' Covid-19 vaccines ENDPOINTS18:05 18-Mar-21
Axial Spondyloarthritis Treatment Market to Witness Highest Growth in Near Future |Pfizer,… Industry Today15:49 18-Mar-21

      
            
      
    view more headlines
   
      
      
      
9 Apr 21:30
   

NewsNow Classifieds
Jobs

Top Searches

Novartis

Novartis

Latest News

Pharma News Top Stories

UK Top Stories

World Top Stories

NewsNow ClassifiedsJobs Top Searches

NewsNow Classifieds
Jobs

Top Searches